Category: News

NewsASDPFO

Occlutech launches ASD and PFO occluders in South Korea

Jena, Germany – Occlutech, a leading European innovator of products to treat structural heart disease today announced that it is making its range of PFO and ASD occluders available on the South Korean market…

Read More
News

Occlutech wins Invalidation of St Jude Patent

Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London, that invalidates AGA/St Jude ́s patent -EP0957773B1 in the UK…

Read More
NewsPLD

Occlutech PLD

I ́m excited to share with you the very first success stories using the Occlutech PLD Occluder for paravalvular leak closure.The Occlutech PLD Occluder is the first CE marked device which offers an alternative treatment for paravalvular leak closure in patients after surgical Mitral & Aortic Valve replacement…

Read More
News

Occlutech wins Swedish Appeal Court Ruling against AGA St Jude Medical

Occlutech International AB, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable judgement from the Appeal Court in Stockholm, Sweden in the on-going patent litigation with AGA/St Jude Medical…

Read More
News

Occlutech Group Acquires NonWoTecc Medical GmbH

Schaffhausen, Switzerland January 12, 2013 – Occlutech Holding AG today announced it has successfully completed the all-share acquisition of NonWoTecc Medical GmbH, a privately-held nanotechnology company based in Cologne, Germany…

Read More
News

Occlutech wins the 2012 Excellence in Medtech Award

The European Tech Tour Association, an independant, not-for-profit organization committed to the development of emerging technology companies from Europe, announced that it has selected Occlutech to receive the 2012 Excellence in Medtech Award…

Read More
News

Occlutech wins patent ruling against St Jude-AGA Medical in Italy

Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally invasive cardiac implants, today announced that it got a favorable ruling in patent litigation with St Jude-AGA Medical from the District Court of Milan in Italy…

Read More
NewsASDPFO

Occlutech wins German Supreme Court ruling against AGA / St. Jude Medical

Occlutech GmbH, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced that it has received a favourable court ruling from the German Supreme Court, (BGH), in Karlsruhe, Gerrmany in patent litigation initiated by AGA Medical Inc., now part of St. Jude Medical Inc…

Read More
News

Occlutech wins Swedish court ruling against AGA-St Jude Medical

Occlutech International AB, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable judgement from the Appeal Court in Stockholm, Sweden in the on-going patent litigation with AGA/St Jude Medical…

Read More

We use cookies to customize content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. Learn more